Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

United Natural Foods Revises Fiscal Year 2024 Forecast

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Food Retailers Trading online
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

United Natural Foods has revised its fiscal year 2024 forecast on March 6, 2024. The company has narrowed its projected adjusted EPS range from $(0.88)-0.38 to $(0.56)-0.06 and its sales guidance from $30.90B-31.50B to $30.50B-31.00B. Additionally, adjustments have been made to the net loss, EPS, adjusted EBITDA, and capital expenditures outlook for the fiscal year ending August 3, 2024. These updates align with United Natural Foods’ current financial expectations for the upcoming period.

United Natural Foods, Inc. (UNFI) Stock Declines Slightly on March 6, 2024: What to Expect Next

On March 6, 2024, United Natural Foods, Inc. (UNFI) experienced a slight decline in its stock performance. According to data from CNN Money, UNFI is currently trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates that the stock may be experiencing some downward pressure.

The price of UNFI shares decreased by $0.14 since the market last closed, representing a 0.93% drop. The stock closed at $14.87 on the previous trading day. However, there seems to be some positive movement in pre-market trading, as the stock has risen by $0.03.

Investors should keep an eye on UNFI’s stock performance in the coming days to see if the slight uptick in pre-market trading continues or if the stock experiences further declines. As always, it is important to consult with a financial advisor before making any investment decisions.

UNFI Stock Performance: Revenue Up, Net Income Down – March 6, 2024 Analysis

On March 6, 2024, United Natural Foods Inc. (UNFI) experienced mixed stock performances based on the latest financial data provided by CNN Money. The company reported a total revenue of $30.27 billion for the past year, which represents a 4.65% increase compared to the previous year. However, the total revenue remained flat at $7.55 billion for the first quarter of the current fiscal year.

UNFI also reported a net income of $24.00 million for the past year, showing a significant decrease of 90.32% compared to the previous year. On the other hand, the net income for the first quarter of the current fiscal year improved to -$39.00 million, indicating a 42.65% increase compared to the previous quarter.

Earnings per share (EPS) for UNFI stood at $0.40 for the past year, reflecting a 90.27% decrease compared to the previous year. However, the EPS improved to -$0.66 for the first quarter of the current fiscal year, showing a 42.74% increase compared to the previous quarter.

Overall, UNFI’s financial performance on March 6, 2024, showed a mixed picture. While the company experienced a slight increase in total revenue since last year, the net income and EPS figures exhibited significant declines. However, there was a notable improvement in net income and EPS compared to the previous quarter, indicating some positive momentum for the company.

Tags: UNFI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances

Analyst Upgrades Target Stock with Optimistic Outlook

Finance_ stocks to buy

Trinity Capital Inc Announces Strong Financial Results for Q4 2023

Biopharmaceutical Markets and money (1)

Xeris Biopharma Holdings Reports Strong Fourth Quarter Financial Results

Recommended

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

2 years ago
Portillo's Stock

Leadership Turmoil Sends Portillo’s Shares to New Low

2 months ago
Dine Brands Global Stock

Dine Brands Stock Faces Potential Downturn

1 month ago
Intel Stock

US Government Considers Taking Equity Stake in Intel

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Trending

XRP Stock
Analysis

XRP Market Dynamics: Institutional Pause Meets Accumulation Surge

by Andreas Sommer
January 11, 2026
0

The XRP market is currently defined by a stark divergence in investor behavior. After a powerful rally...

Rocket Lab USA Stock

Rocket Lab’s Stock Momentum Continues Unabated in 2026

January 11, 2026
Eli Lilly Stock

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

January 11, 2026
Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XRP Market Dynamics: Institutional Pause Meets Accumulation Surge
  • Rocket Lab’s Stock Momentum Continues Unabated in 2026
  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com